• Home
  • NEW DAY MEDICINE
  • 9 (59) 2023
  • 15 -9 (59) 2023 — Sultonova L.Dj., Hamdamov B.Z. — CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF NON-HODGKIN’S LYMPHOMAS IN CHILDREN, OPTIMIZATION OF TREATMENT

15 -9 (59) 2023 — Sultonova L.Dj., Hamdamov B.Z. — CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF NON-HODGKIN’S LYMPHOMAS IN CHILDREN, OPTIMIZATION OF TREATMENT

CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF NON-HODGKIN’S LYMPHOMAS IN CHILDREN, OPTIMIZATION OF TREATMENT

Sultonova L.Dj., Bukhara State Medical Institute named after Abu Ali ibn Sino

Hamdamov B.Z., Bukhara State Medical Institute named after Abu Ali ibn Sino

Adizov I.Sh. Bukhara State Medical Institute named after Abu Ali ibn Sino

Resume

Non-Hodgkin’s lymphomas (specialists use the abbreviation NHL for the disease) is a cancer of the lymphatic system. This type of lymphoma refers to malignant lymphomas. The term “malignant lymphoma” literally means “malignant enlargement of the lymph nodes.” Specialists combine in this term a large group of oncological diseases. They all start in the cells of the lymphatic system and their main symptom is an enlargement of the lymph nodes (that is, lymphoma).

Key words: lymphoma, Hodgkin’s disease, symptoms, treatment.

First page

77

Last page

80

For citation: Sultonova L.Dj., Hamdamov B.Z., Adizov I.Sh. – CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF NON-HODGKIN’S LYMPHOMAS IN CHILDREN, OPTIMIZATION OF TREATMENT //New Day in Medicine 2023 9(59): https://newdaymedicine.com/index.php/2023/09/06/l-353/

LIST OF REFERENCES:

  1. Azimova S. Genetic features of the development of chronic hepatitis C //Theoretical aspects in the formation of pedagogical sciences. – 2023;2(2):128-129.
  2. Azimova S. Genetic features of the development of chronic hepatitis C //Theoretical aspects in the formation of pedagogical sciences. 2023;2(2):128-129.
  3. Burkhardt B, Klapper W, Woessmann W: Non-Hodgkin-Lymphome. in: Niemeyer C, Eggert A (Hrsg.): Pädiatrische Hämatologie und Onkologie. Springer-Verlag GmbH Deutschland, 2. vollständig überarbeitete Auflage 2018;324 [ISBN: 978-3-662-43685-1]
  4. Burkhardt B, Wössmann W: Non-Hodgkin-Lymphome. S1-Leitlinie 025/013: Non-Hodgkin-Lymphome im Kindes- und Jugendalter 2017 [URI: https://www.awmf.org/ uploads/ tx_szleitlinien/ 025-013l_S1_Non-Hodgkin-Lymphome_NHL_2017-05-abgelaufen.pdf]
  5. Erdmann F, Kaatsch P, Grabow D, Spix C: German Childhood Cancer Registry – Annual Report 2019 (1980-2018). Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) at the University Medical Center of the Johannes Gutenberg University Mainz 2020 [URI: https://www.kinderkrebsregister.de/ typo3temp/ secure_downloads/ 42507/ 0/ 1c5976c2ab8af5b6b388149df7182582a4cd6a39/ Buch_DKKR_Jahresbericht_ 2019_komplett.pdf]
  6. Ezoza F. Development and insurance of foreign economic activity in the republic of Uzbekistan with the help of foreign Investments //American Journal Of Social Sciences And Humanity Research. 2023;3(7):33-44.
  7. Ferris Tortajada J, Garcia Castell J, Berbel Tornero O, Clar Gimeno S: Risk factors for non-Hodgkin’s lymphomas. An Esp Pediatr 2001;55:230 [PMID: 11676898]
  8. Karimov K., Azimova S., Iriskulov B. Immunogenetic Aspects Of Pathogenesis Of Chronic Hcv-Infection //European Medical, Health and Pharmaceutical Journal. 2012;4.
  9. Le Deley MC, Reiter A, Williams D, Delsol G, Oschlies I, McCarthy K, Zimmermann M, Brugières L, European Intergroup for Childhood Non-Hodgkin Lymphoma: Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study. Blood 2008;111:1560 [PMID: 17957029]
  10. Murphy SB: Classification, staging and end results of treatment of childhood non-Hodgkins-lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 1980;7:332 [PMID: 7414342]
  11. Reiter A, Schrappe M, Ludwig W, Tiemann M, Parwaresch R, Zimmermann M, Schirg E, Henze G, Schellong G, Gadner H, Riehm H: Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma. Blood 2000;95:416 [PMID: 10627444]
  12. Reiter A: Non-Hodgkin Lymphoma in Children and Adolescents. Klinische Padiatrie 2013;225(S 01):S87-S93 [PMID: 23700066]
  13. Rosolen A, Perkins SL, Pinkerton CR, Guillerman RP, Sandlund JT, Patte C, Reiter A, Cairo MS: Revised International Pediatric Non-Hodgkin Lymphoma Staging System. //Journal of clinical oncology 2015;33:2112 [PMID: 25940716]
  14. Salzburg J, Burkhardt B, Zimmermann M, Wachowski O, Woessmann W, Oschlies I, Klapper W, Wacker HH, Ludwig WD, Niggli F, Mann G, Gadner H, Riehm H, Schrappe M, Reiter A: Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin’s lymphoma differ by non-Hodgkin’s lymphoma subtype: a Berlin-Frankfurt-Münster Group Report. //Journal of clinical oncology 2007;25:3915 [PMID: 17761975]
  15. Stanulla M, Erdmann F, Kratz CP: Risikofaktoren für Krebserkrankungen im Kindes- und Jugendalter. Monatsschrift Kinderheilkunde 169, 30-38 2021 [DOI: 10.1007/s00112-020-01083-8]
  16. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Eds): WHO Classification of Tumours of the Haematopoetic and Lymphoid Tissues. Lyon, France: IARC Press 2008;109.
  17. Thorer H, Zimmermann M, Makarova O, Oschlies I, Klapper W, Lang P, von Stackelberg A, Fleischhack G, Worch J, Jürgens H, Woessmann W, Reiter A, Burkhardt B: Primary central nervous system lymphoma in children and adolescents: low relapse rate after treatment according to Non-Hodgkin-Lymphoma Berlin-Frankfurt-Münster protocols for systemic lymphoma. Haematologica 2014, [PMID: 25107886]
  18. Каримов Х. Я., Азимова С. Б., Бобоев К. Т. Анализ генотипических вариантов полиморфизма гена CYP2C9 в узбекской популяции //Міжнароний медичний журнал. 2012;18(4):106-109.

file

download